Lido Advisors, LLC Protalix Bio Therapeutics, Inc. Transaction History
Lido Advisors, LLC
- $20.3 Billion
- Q3 2024
A detailed history of Lido Advisors, LLC transactions in Protalix Bio Therapeutics, Inc. stock. As of the latest transaction made, Lido Advisors, LLC holds 15,554 shares of PLX stock, worth $41,840. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,554
Previous 15,554
-0.0%
Holding current value
$41,840
Previous $18,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding PLX
# of Institutions
51Shares Held
3.45MCall Options Held
61.1KPut Options Held
36.2K-
Jim Simons Renaissance Technologies LLC | New York, Ny956KShares$2.57 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny374KShares$1.01 Million0.0% of portfolio
-
Black Rock Inc. New York, NY333KShares$896,2290.0% of portfolio
-
Gsa Capital Partners LLP London, X0306KShares$822,4640.04% of portfolio
-
Stratos Wealth Partners, Ltd.270KShares$726,3000.01% of portfolio
About Protalix BioTherapeutics, Inc.
- Ticker PLX
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,753,400
- Market Cap $134M
- Description
- Protalix BioTherapeutics, Inc., a biopharmaceutical company, focuses on the development and commercialization of recombinant therapeutic proteins based on its proprietary ProCellEx plant cell-based protein expression system in the United States, Australia, Canada, Israel, Brazil, Russia, Turkey, and internationally. The company offers Elelyso fo...